Rate My Professor Nevin John

John’s research specializations encompass multiple sclerosis epidemiology—including geospatial analyses, risk factors, comorbidities, and their effects on disease outcomes—alongside advanced neuroimaging (MRI and optical coherence tomography), pregnancy-related changes in MS, and biomarkers for neuroinflammatory conditions such as adult-onset leukodystrophy. He is site primary investigator for the international MSBase registry and contributes to clinical trial design. Notable grants include the NHMRC Ideas Grant (ID 2037776, $1,359,383) for investigating pregnancy’s impact on the MS brain, MRFF grant (2024553, $2,000,000) exploring Epstein-Barr virus’s role in MS pathogenesis via OCCAMS, and MRFF (2032017, $1,498,776) for a pilot intervention enhancing bone health and muscle strength in MS patients. Key publications feature co-authorship in “Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1 and 2” (Medical Journal of Australia, 2025), “Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years” (Journal of Neurology, Neurosurgery & Psychiatry, 2025), and “Estimation of Transition Probabilities from a Large Cohort (>6000) of Australians Living with Multiple Sclerosis” (PharmacoEconomics, 2025). His work advances understanding and management of MS, supported by collaborations in international MS research networks.